Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-006394
Filing Date
2025-05-06
Accepted
2025-05-06 08:15:31
Documents
91
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hrmy-20250331x10q.htm   iXBRL 10-Q 1495543
2 EX-31.1 hrmy-20250331xex31d1.htm EX-31.1 16171
3 EX-31.2 hrmy-20250331xex31d2.htm EX-31.2 16747
4 EX-32.1 hrmy-20250331xex32d1.htm EX-32.1 9872
5 EX-32.2 hrmy-20250331xex32d2.htm EX-32.2 9398
  Complete submission text file 0001558370-25-006394.txt   8303861

Data Files

Seq Description Document Type Size
6 EX-101.SCH hrmy-20250331.xsd EX-101.SCH 67591
7 EX-101.CAL hrmy-20250331_cal.xml EX-101.CAL 79705
8 EX-101.DEF hrmy-20250331_def.xml EX-101.DEF 183411
9 EX-101.LAB hrmy-20250331_lab.xml EX-101.LAB 557640
10 EX-101.PRE hrmy-20250331_pre.xml EX-101.PRE 389131
94 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20250331x10q_htm.xml XML 1496461
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39450 | Film No.: 25915363
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)